Multi-agency guidance for 1915(c) Children’s Waiver Home and Community-Based Services regarding respite services. Issued April 8, 2020.

NYS DOH updated guidance on the state response to the COVID-19 outbreak and the state disaster emergency declared by Executive Order No. 202. Issued April...

Guidance from NYS DOH to Health Maintenance Organizations (HMO), Prepaid Health Services Plans (PHSP), comprehensive HIV Special Needs Plans (HIV SNP), Health and Recovery Plans (HARP) and...

Guidance from the Department of Health Office of Health Insurance Programs regarding the use of ibuprofen in the treatment of COVID-19. issued April 7, 2020.

NYS DOH guidance for understanding the risks to contacts of suspected or confirmed cases of COVID-19. Issued 4/3/20.

Health advisory from the NYS Department of Health to all providers and practitioners outlining options for when personal protective equipment (PPE) is in short supply or...

Drug Enforcement Administration guidance allowing for more flexibility for practitioners to prescribe buprenorphine to new and existing patients with OUD via telephone during the nationwide public health emergency...

NYS Department of Health: protocols for essential personnel to return to work following COVID-19 exposure or infection. Updated 03/28/20.

OASAS guidance on the Drug Enforcement Administration's recent action of approving buprenorphine induction via telephone amid the COVID-19 pandemic.

COVID-19 guidance for Impaired Driver Screening and Assessment service providers.